<DOC>
	<DOC>NCT02273947</DOC>
	<brief_summary>The purpose of this study is to assess the impact of a light meal, a standard meal, and a high fat meal on the PK of BMS-955176 MC tablet at a dose of 180 mg, relative to fasted conditions.</brief_summary>
	<brief_title>Food Effect Study With BMS-955176</brief_title>
	<detailed_description>Primary Purpose Other: This study will assess the impact of a light meal, a standard meal, and a high fat meal on the pharmacokinetics (PK) of BMS-955176 micronized crystalline (MC) tablet at a dose of 180 mg relative to fasted conditions.</detailed_description>
	<criteria>For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com Healthy subjects as determined by no clinically significant deviation from normal in medical history, physical examinations, vital sign measurements, 12lead ECG measurements, and clinical laboratory test results Body mass index (BMI) of 18.0 to 32.0 kg/m2, inclusive. BMI = Weight (kg)/[Height (m)]2 Men and women, ages 18 to 50 years, inclusive Women must not be of childbearing potential, must not be breastfeeding Any significant acute or chronic medical illness History of cardiac disease or clinically significant cardiac arrhythmias Current or recent (within 3 months of study drug administration) gastrointestinal disease Any major surgery within 4 weeks of study drug administration Any gastrointestinal surgery (including cholecystectomy) that could impact upon the absorption of study drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>